Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers
Year: 2020
Type: article
Study design: Observational Study
Abstract: INTRODUCTION: Sustained high alcohol intake is necessary but not sufficient to produce alcohol-related cirrhosis. Identification of risk factors, apart from lifetime alcohol exposure, would assist in discovery of mechanisms and prediction of risk. METHODS: We conducted a multicenter case-control study (GenomALC) comparing 1,293 cases (with alcohol-related cirrhosis, 75.6% male) and 754 controls (with equivalent alcohol exposure but no evidence of liver disease, 73.6% male). Information confirming or excluding cirrhosis, and on alcohol intake and other potential risk factors, was obtained from clinical records and by interview. Case-control differences in risk factors discovered in the GenomALC participants were validated using similar data from 407 cases and 6,573 controls from UK Biobank. RESULTS: The GenomALC case and control groups reported similar lifetime alcohol intake (1,374 vs 1,412 kg). Cases had a higher prevalence of diabetes (20.5% (262/1,288) vs 6.5% (48/734), P = 2.27 × 10-18) and higher premorbid body mass index (26.37 ± 0.16 kg/m2) than controls (24.44 ± 0.18 kg/m2, P = 5.77 × 10-15). Controls were significantly more likely to have been wine drinkers, coffee drinkers, smokers, and cannabis users than cases. Cases reported a higher proportion of parents who died of liver disease than controls (odds ratio 2.25 95% confidence interval 1.55-3.26). Data from UK Biobank confirmed these findings for diabetes, body mass index, proportion of alcohol as wine, and coffee consumption. DISCUSSION: If these relationships are causal, measures such as weight loss, intensive treatment of diabetes or prediabetic states, and coffee consumption should reduce the risk of alcohol-related cirrhosis.
Authors: John B. Whitfield, Steven Masson, Suthat Liangpunsakul, Sebastian Mueller, Guruprasad P. Aithal, Florian Eyer, Dermot Gleeson, Andrew Thompson, Felix Stickel, Michael Soyka, Beat Muellhaupt, Ann K. Daly, Heather J. Cordell, Tatiana Foroud, Lawrence Lumeng, Munir Pirmohamed, Bertrand Nalpas, Jean-Marc Jacquet, Romain Moirand, Pierre Nahon, Sylvie Naveau, Pascal Perney, Paul S. Haber, Helmut K. Seitz, Christopher P. Day, Philippe Mathurin, Timothy R. Morgan, Devanshi Seth
Institutions: QIMR Berghofer Medical Research Institute, Newcastle University, Indiana University Indianapolis, Indiana University School of Medicine, Heidelberg University, University of Nottingham, National Institute for Health and Care Research, Nottingham Biomedical Research Centre, TUM Klinikum, Technical University of Munich, Royal Hallamshire Hospital, University of Liverpool, University Hospital Zurich, Privatklinik Meiringen, Ludwig-Maximilians-Universität München, Centre for Life, Inserm, Centre Hospitalier Universitaire de Nîmes, Centre Hospitalier Universitaire de Rennes, Nutrition, métabolismes et cancer, Université de Rennes, Université Sorbonne Paris Nord, Génomique Fonctionnelle des Tumeurs Solides, Hôpital Jean-Verdier, Hôpital Antoine-Béclère, The University of Sydney, Royal Prince Alfred Hospital, Centre Hospitalier Universitaire de Lille, Hôpital Claude Huriez, University of California, Irvine, VA Long Beach Healthcare System, Centenary Institute
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3047754103
